chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate irregular, Myalgia, Vaccination site pain
Clinical narrative: FEELING A LITTLE BIT WIERD; difficulty breathing; MEASURED HEART BEAT HAS BEEN VARIABLE; DISBALANCE; FATIGUE; MUSCLE PAIN; JOINT PAIN; A LITTLE BIT OF PAIN AT THE INJECTION SITE; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE IRREGULAR (MEASURED HEART BEAT HAS BEEN VARIABLE), DYSPNOEA (difficulty breathing), FEELING ABNORMAL (FEELING A LITTLE BIT WIERD), BALANCE DISORDER (DISBALANCE) and VACCINATION SITE PAIN (A LITTLE BIT OF PAIN AT THE INJECTION SITE) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M207) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Sciatic hernia, Stress (stress disorder) and Prostate infection. Concomitant products included METOPROLOL for Hypertension, ACETYLSALICYLIC ACID (ASPRIN), FISH OIL, OENOTHERA BIENNIS OIL, TOCOPHERYL ACETATE (OMEGA 3 & 6) and CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID) for an unknown indication.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (A LITTLE BIT OF PAIN AT THE INJECTION SITE). On 18-Feb-2021, the patient experienced HEART RATE IRREGULAR (MEASURED HEART BEAT HAS BEEN VARIABLE), BALANCE DISORDER (DISBALANCE), FATIGUE (FATIGUE), MYALGIA (MUSCLE PAIN) and ARTHRALGIA (JOINT PAIN). On 19-Feb-2021, the patient experienced DYSPNOEA (difficulty breathing). On 22-Feb-2021, the patient experienced FEELING ABNORMAL (FEELING A LITTLE BIT WIERD). At the time of the report, HEART RATE IRREGULAR (MEASURED HEART BEAT HAS BEEN VARIABLE), DYSPNOEA (difficulty breathing), FEELING ABNORMAL (FEELING A LITTLE BIT WIERD), BALANCE DISORDER (DISBALANCE), FATIGUE (FATIGUE), MYALGIA (MUSCLE PAIN) and ARTHRALGIA (JOINT PAIN) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tazulozil 0.4 mg for prostate.   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2021: Follow-up received on 22-02-2021: No new information
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: blood/fluid leak; A spontaneous report was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  blood fluid leak/vaccination site hemorrhage.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced blood fluid leak/vaccination site hemorrhage.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   on an unknown date the outcome of blood fluid leak/vaccination site hemorrhage was unknown.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Asthenia, Decreased appetite, Dizziness, Dyspnoea, Nausea
Clinical narrative: lack of appetite; shortness of breath; nausea; extreme neck pain; dizziness; weakness; A spontaneous report was received from a  concerning female patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  and experienced extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath.  The patient's medical history, was not reported. Concomitant medications included Amoxicillin, Metronidazole, Zetia, HCTZ, Losartan, Singulair, Effexor, Calcium, Vitamin D, Aspirin.  On 17-Feb-2021, the patient received their second of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  Experienced extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath. Treatment taken included Tylenol, Advil.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events,extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath.  were unknown
Sex: F
Vaccine: COVID19, UNK
Symptoms: Neck pain
Clinical narrative: lack of appetite; shortness of breath; nausea; extreme neck pain; dizziness; weakness; A spontaneous report was received from a  concerning female patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  and experienced extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath.  The patient's medical history, was not reported. Concomitant medications included Amoxicillin, Metronidazole, Zetia, HCTZ, Losartan, Singulair, Effexor, Calcium, Vitamin D, Aspirin.  On 17-Feb-2021, the patient received their second of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  Experienced extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath. Treatment taken included Tylenol, Advil.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events,extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath.  were unknown
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: achy back and body; slept through the night; swelling and warmth on the left deltoid; Chills; Fever 100.7; chills; swelling and warmth on the left deltoid; right arm was achy and achy all over; A spontaneous report was received from a consumer concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events swelling and warmth on the left deltoid, right arm was achy and achy all over, chills, fever 100.7, slept through the night, achy back and body.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 007M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 18 Feb 2021, the patient experienced the events swelling and warmth on the left deltoid, right arm was achy and achy all over, chills, fever 100.7. On 19 Feb 2021, the patient experienced the events slept through the night. On an unknown date, the patient experienced the events achy back and body.She wanted to know if these side effects we normal.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, swelling and warmth on the left deltoid, right arm was achy and achy all over, chills, fever 100, 7, slept through the night, achy back and body was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site swelling, Vaccination site warmth
Clinical narrative: achy back and body; slept through the night; swelling and warmth on the left deltoid; Chills; Fever 100.7; chills; swelling and warmth on the left deltoid; right arm was achy and achy all over; A spontaneous report was received from a consumer concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events swelling and warmth on the left deltoid, right arm was achy and achy all over, chills, fever 100.7, slept through the night, achy back and body.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 007M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 18 Feb 2021, the patient experienced the events swelling and warmth on the left deltoid, right arm was achy and achy all over, chills, fever 100.7. On 19 Feb 2021, the patient experienced the events slept through the night. On an unknown date, the patient experienced the events achy back and body.She wanted to know if these side effects we normal.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, swelling and warmth on the left deltoid, right arm was achy and achy all over, chills, fever 100, 7, slept through the night, achy back and body was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain
Clinical narrative: sore throat that lasted for 24-36 hour; Slept all day due to Fatigue; A spontaneous report was received from a consumer concerning a 65-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore throat that lasted for 24-36 hour, just slept all day due to fatigue.  The patient's medical history was not provided. Concomitant medications reported were eliquis, Ambien, Atorvastatin for drug use for unknown indication.  On 3 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 038K20A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) sore throat that lasted for 24-36 hour, just slept all day due to fatigue.  Treatment details included as  no treatment taken.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), sore throat that lasted for 24-36 hour, just slept all day due to fatigue was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site soreness; A spontaneous report, was received from a  consumer concerning a female patient, , who was administered Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site soreness.  The patient's medical history and concomitant history was not provided by the reporter , no lab data was reported .    on  22 FEB 2021 the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 22 FEB 2021, the patient experienced  injection site soreness. the outcome of the events was unknown.   The treatment history was not provided.  The Action taken with the first dose of mRNA-1273 in response to the event was not reported.  The  outcome of the events were considered as unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Pain in extremity
Clinical narrative: leg pain; flu like symptoms; headache; A spontaneous report reported by a consumer concerning a female patient of unknown age who received Moderna's COVID vaccine and experienced the events leg pain , headache and flu-like symptoms.  The patient's medical history was not provided .Concomitant medications were not reported.  On 15 Feb 2021 , prior to the onset of the event, the patient received first of two planned doses of   mRNA-1273 (batch number-unknown)  via unknown route of administration for prophylaxis of COVID 19 infection.  On an unknown date, the patient experienced event like leg pain, headache and flu -like symptoms.   No treatment medications were reported.  Action taken with mRNA-1273 in response to event was unknown.  Outcome of the events  like leg pain, headache and flu -like symptoms were considered to be unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pain in extremity
Clinical narrative: arm soreness; Second dose 2 weeks after the first one; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 2 weeks after the first one) and PAIN IN EXTREMITY (arm soreness) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 2 weeks after the first one). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). On 23-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 2 weeks after the first one) had resolved. At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Follow-up information received captured patient demographics, suspect drug information and event. On 15-Apr-2021: Follow-up information received captured no new information.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot # 013M20A for second dose) with no associated AEs reported.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Malaise, Nausea
Clinical narrative: abdominal pain; not felt well; nauseated; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain), MALAISE (not felt well) and NAUSEA (nauseated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (abdominal pain), MALAISE (not felt well) and NAUSEA (nauseated). At the time of the report, ABDOMINAL PAIN (abdominal pain), MALAISE (not felt well) and NAUSEA (nauseated) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's age is in late 20's. Treatment information not provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Injection site reaction, Muscle spasms, Pain in extremity, Paraesthesia
Clinical narrative: standard reaction; slight aching in left shoulder the first couple of nights; became sensitive and it was like walking into a spider web; Tingling sensation around the right ear and in the hairline; extreme tension in both legs; more in my left leg than my right leg; like a cramp; difficult to walk; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (standard reaction), VACCINATION SITE PAIN (slight aching in left shoulder the first couple of nights), PHANTOM LIMB SYNDROME (became sensitive and it was like walking into a spider web), PARAESTHESIA (Tingling sensation around the right ear and in the hairline) and TENSION (extreme tension in both legs) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On an unknown date, the patient experienced INJECTION SITE REACTION (standard reaction), VACCINATION SITE PAIN (slight aching in left shoulder the first couple of nights), PHANTOM LIMB SYNDROME (became sensitive and it was like walking into a spider web), PARAESTHESIA (Tingling sensation around the right ear and in the hairline), TENSION (extreme tension in both legs), PAIN IN EXTREMITY (more in my left leg than my right leg), MUSCLE SPASMS (like a cramp) and GAIT DISTURBANCE (difficult to walk).   At the time of the report, INJECTION SITE REACTION (standard reaction), VACCINATION SITE PAIN (slight aching in left shoulder the first couple of nights), PHANTOM LIMB SYNDROME (became sensitive and it was like walking into a spider web), PARAESTHESIA (Tingling sensation around the right ear and in the hairline), TENSION (extreme tension in both legs) and PAIN IN EXTREMITY (more in my left leg than my right leg) was resolving and GAIT DISTURBANCE (difficult to walk) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It is reported that on 25-FEB-2021, Patient was massaging the tendon on the top of his left foot in the middle of the night.   This case was linked to MOD-2021-026627 (Patient Link).
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Phantom limb syndrome, Tension, Vaccination site pain
Clinical narrative: standard reaction; slight aching in left shoulder the first couple of nights; became sensitive and it was like walking into a spider web; Tingling sensation around the right ear and in the hairline; extreme tension in both legs; more in my left leg than my right leg; like a cramp; difficult to walk; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (standard reaction), VACCINATION SITE PAIN (slight aching in left shoulder the first couple of nights), PHANTOM LIMB SYNDROME (became sensitive and it was like walking into a spider web), PARAESTHESIA (Tingling sensation around the right ear and in the hairline) and TENSION (extreme tension in both legs) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On an unknown date, the patient experienced INJECTION SITE REACTION (standard reaction), VACCINATION SITE PAIN (slight aching in left shoulder the first couple of nights), PHANTOM LIMB SYNDROME (became sensitive and it was like walking into a spider web), PARAESTHESIA (Tingling sensation around the right ear and in the hairline), TENSION (extreme tension in both legs), PAIN IN EXTREMITY (more in my left leg than my right leg), MUSCLE SPASMS (like a cramp) and GAIT DISTURBANCE (difficult to walk).   At the time of the report, INJECTION SITE REACTION (standard reaction), VACCINATION SITE PAIN (slight aching in left shoulder the first couple of nights), PHANTOM LIMB SYNDROME (became sensitive and it was like walking into a spider web), PARAESTHESIA (Tingling sensation around the right ear and in the hairline), TENSION (extreme tension in both legs) and PAIN IN EXTREMITY (more in my left leg than my right leg) was resolving and GAIT DISTURBANCE (difficult to walk) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It is reported that on 25-FEB-2021, Patient was massaging the tendon on the top of his left foot in the middle of the night.   This case was linked to MOD-2021-026627 (Patient Link).
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: redness; itchiness; rash under the neck; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), PRURITUS (itchiness) and RASH (rash under the neck) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023MDUA) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included AMLODIPINE and LOSARTAN for Hypertension.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ERYTHEMA (redness), PRURITUS (itchiness) and RASH (rash under the neck). At the time of the report, ERYTHEMA (redness), PRURITUS (itchiness) and RASH (rash under the neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Investigation, Pregnancy test, Ultrasound scan
Clinical narrative: Pregnant patient got the first dose and second dose; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant patient got the first dose and second dose) in a 27-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient had no allergies to medications, food and other products.  The patient's past medical history included Pregnancy (Live , pre-term birth at < or = 37 weeks of gestation). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 17-Aug-2021. On 26-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant patient got the first dose and second dose). On 24-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant patient got the first dose and second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Dec-2020, Pregnancy test: pregnancy positive (Positive) pregnancy positive. On an unknown date, Investigation: normal (normal) normal. On an unknown date, Ultrasound scan: normal (normal) Everything normal in 3 ultrasounds.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient did not have history of substance abuse. Treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersensitivity, Nasal congestion
Clinical narrative: congestion; allergies; headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion), HYPERSENSITIVITY (allergies) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced NASAL CONGESTION (congestion), HYPERSENSITIVITY (allergies) and HEADACHE (headache). At the time of the report, NASAL CONGESTION (congestion), HYPERSENSITIVITY (allergies) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included Open heart surgery (In July) and Defibrillator/pacemaker insertion.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced COVID-19 (tested positive for covid). The patient was treated with DOXYCYCLINE for COVID-19, at a dose of 100 mg and DEXAMETHASONE for COVID-19, at a dose of 4 mg. At the time of the report, COVID-19 (tested positive for covid) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included blood thinners, diabetes medications, cholesterol medications and high blood pressure medications. treatment also included breathing treatments three times daily.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Dyspnoea, Fatigue
Clinical narrative: Tingling; Back pain; Hard time catching her breath; Muscle pain; Fatigue; Nausea; Chills; Joint pain; Couldn't lift her arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling), BACK PAIN (Back pain), DYSPNOEA (Hard time catching her breath), MYALGIA (Muscle pain) and FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling), BACK PAIN (Back pain), DYSPNOEA (Hard time catching her breath), MYALGIA (Muscle pain), FATIGUE (Fatigue), NAUSEA (Nausea), CHILLS (Chills), ARTHRALGIA (Joint pain) and ARTHRALGIA (Couldn't lift her arm). At the time of the report, PARAESTHESIA (Tingling), BACK PAIN (Back pain), DYSPNOEA (Hard time catching her breath), MYALGIA (Muscle pain), FATIGUE (Fatigue), NAUSEA (Nausea), CHILLS (Chills), ARTHRALGIA (Joint pain) and ARTHRALGIA (Couldn't lift her arm) outcome was unknown.            No relevant concomitant medications reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Paraesthesia
Clinical narrative: Tingling; Back pain; Hard time catching her breath; Muscle pain; Fatigue; Nausea; Chills; Joint pain; Couldn't lift her arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling), BACK PAIN (Back pain), DYSPNOEA (Hard time catching her breath), MYALGIA (Muscle pain) and FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling), BACK PAIN (Back pain), DYSPNOEA (Hard time catching her breath), MYALGIA (Muscle pain), FATIGUE (Fatigue), NAUSEA (Nausea), CHILLS (Chills), ARTHRALGIA (Joint pain) and ARTHRALGIA (Couldn't lift her arm). At the time of the report, PARAESTHESIA (Tingling), BACK PAIN (Back pain), DYSPNOEA (Hard time catching her breath), MYALGIA (Muscle pain), FATIGUE (Fatigue), NAUSEA (Nausea), CHILLS (Chills), ARTHRALGIA (Joint pain) and ARTHRALGIA (Couldn't lift her arm) outcome was unknown.            No relevant concomitant medications reported.  No treatment information was provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Limb discomfort, Pain in extremity, Vaccination site pain
Clinical narrative: can't lift anything heavy with her right arm; right arm pain all over; arm pain is now "in the shot area and shoulder"; The shoulder area is hurting and hurts further down towards the elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (right arm pain all over), LIMB DISCOMFORT (can't lift anything heavy with her right arm), VACCINATION SITE PAIN (arm pain is now "in the shot area and shoulder") and ARTHRALGIA (The shoulder area is hurting and hurts further down towards the elbow) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus and Hypothyroidism. Concomitant products included LEVOTHYROXINE for Hypothyroidism.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PAIN (arm pain is now "in the shot area and shoulder") and ARTHRALGIA (The shoulder area is hurting and hurts further down towards the elbow). On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (right arm pain all over). On an unknown date, the patient experienced LIMB DISCOMFORT (can't lift anything heavy with her right arm). At the time of the report, PAIN IN EXTREMITY (right arm pain all over), VACCINATION SITE PAIN (arm pain is now "in the shot area and shoulder") and ARTHRALGIA (The shoulder area is hurting and hurts further down towards the elbow) had not resolved and LIMB DISCOMFORT (can't lift anything heavy with her right arm) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medicines include Tylenol and Aspirin  Patient states that The shoulder area is hurting and hurts further down towards the elbow. it hurts in different part of arm, and mostly where she got the vaccine. The pain is not severe but its achy.   This case was linked to MOD-2021-100636 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: updated details of events, outcome of the events pain in extremity, Injection site pain, Arthralgia, from unknown to Not Recovered. details of second dose added. Updated action taken from unknown to No change
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Platelet disorder
Clinical narrative: Drop in platelets; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PLATELET DISORDER (Drop in platelets) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PLATELET DISORDER (Drop in platelets). At the time of the report, PLATELET DISORDER (Drop in platelets) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported No treatment medication were reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Mobility decreased, Muscular weakness, Pain, Pain in extremity
Clinical narrative: arm got very sore; unable to raise arm up and out; can not lift items; weak; painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm got very sore), MOBILITY DECREASED (unable to raise arm up and out), MUSCULAR WEAKNESS (can not lift items), ASTHENIA (weak) and PAIN (painful) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported). Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), NABUMETONE (RELAFEN), LISINOPRIL and FAMOTIDINE (PEPCID AC) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm got very sore), MOBILITY DECREASED (unable to raise arm up and out), MUSCULAR WEAKNESS (can not lift items), ASTHENIA (weak) and PAIN (painful). At the time of the report, PAIN IN EXTREMITY (arm got very sore), MOBILITY DECREASED (unable to raise arm up and out), MUSCULAR WEAKNESS (can not lift items), ASTHENIA (weak) and PAIN (painful) outcome was unknown. Not Provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Swelling face
Clinical narrative: Heat; Facial swelling; Redness; This spontaneous case was reported by an other health care professional and describes the occurrence of FEELING HOT (Heat), SWELLING FACE (Facial swelling) and ERYTHEMA (Redness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Endometrial carcinoma. Concomitant products included LENVATINIB MESILATE (LENVIMA) and PEMBROLIZUMAB (KEYTRUDA) from 11-Feb-2021 to an unknown date for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced FEELING HOT (Heat), SWELLING FACE (Facial swelling) and ERYTHEMA (Redness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 19-Feb-2021, SWELLING FACE (Facial swelling) and ERYTHEMA (Redness) had resolved. At the time of the report, FEELING HOT (Heat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Regulatory Authority
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Cough
Clinical narrative: Coughing and loosing her voice because of dry cough; Loosing her voice because of dry cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing and loosing her voice because of dry cough) and APHONIA (Loosing her voice because of dry cough) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Ovarian cancer. Concomitant products included OLAPARIB (LYNPARZA) for Ovarian cancer.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced COUGH (Coughing and loosing her voice because of dry cough) and APHONIA (Loosing her voice because of dry cough). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COUGH (Coughing and loosing her voice because of dry cough) and APHONIA (Loosing her voice because of dry cough) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered more than six hours after the initial puncture of the vial by 16 minutes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered more than six hours after the initial puncture of the vial by 16 minutes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered more than six hours after the initial puncture of the vial by 16 minutes). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered more than six hours after the initial puncture of the vial by 16 minutes) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Reporter's Comments: This report refers to a case of expired product administered for mRNA-1273 with no associated AEs.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Experiencing tingling in both arms; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Experiencing tingling in both arms) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PARAESTHESIA (Experiencing tingling in both arms). At the time of the report, PARAESTHESIA (Experiencing tingling in both arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills
Clinical narrative: Weakness - was in bed for 36 hrs; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness - was in bed for 36 hrs) and CHILLS (Chills) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced ASTHENIA (Weakness - was in bed for 36 hrs) and CHILLS (Chills). On 06-Feb-2021, ASTHENIA (Weakness - was in bed for 36 hrs) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-028005 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-028005:Crosslinked case
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia
Clinical narrative: Left arm sore; Left side of the neck there was a nodule (little swollen); This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Left arm sore) and LYMPHADENOPATHY (Left side of the neck there was a nodule (little swollen)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. L023M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 virus test positive in September 2020.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 26-Feb-2021, the patient experienced MYALGIA (Left arm sore) and LYMPHADENOPATHY (Left side of the neck there was a nodule (little swollen)). At the time of the report, MYALGIA (Left arm sore) and LYMPHADENOPATHY (Left side of the neck there was a nodule (little swollen)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not report concomitant medications because the list was too long.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: TCR received: Event outcome updated to resolved.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth, Limb discomfort
Clinical narrative: A little Discomfort in Triceps Area on the Left Arm; Very Itchy Injection Site; Warm to the touch Injection Site; Red from Shoulder to elbow; Swelling on the Injection Site; Pain on the Injection Site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE WARMTH (Warm to the touch Injection Site), VACCINATION SITE REACTION (Red from Shoulder to elbow), LIMB DISCOMFORT (A little Discomfort in Triceps Area on the Left Arm), INJECTION SITE PRURITUS (Very Itchy Injection Site) and INJECTION SITE SWELLING (Swelling on the Injection Site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE SWELLING (Swelling on the Injection Site) and INJECTION SITE PAIN (Pain on the Injection Site). On 19-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm to the touch Injection Site), VACCINATION SITE REACTION (Red from Shoulder to elbow) and INJECTION SITE PRURITUS (Very Itchy Injection Site). On 26-Feb-2021, the patient experienced LIMB DISCOMFORT (A little Discomfort in Triceps Area on the Left Arm). The patient was treated with CEFALEXIN MONOHYDRATE (KEFLEX [CEFALEXIN MONOHYDRATE]) at a dose of 500 mg four times per day. At the time of the report, INJECTION SITE WARMTH (Warm to the touch Injection Site), VACCINATION SITE REACTION (Red from Shoulder to elbow), LIMB DISCOMFORT (A little Discomfort in Triceps Area on the Left Arm), INJECTION SITE PRURITUS (Very Itchy Injection Site), INJECTION SITE SWELLING (Swelling on the Injection Site) and INJECTION SITE PAIN (Pain on the Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Other treatment medications include Benadryl cream and  Ice pack on the area for an unknown indication.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: A little Discomfort in Triceps Area on the Left Arm; Very Itchy Injection Site; Warm to the touch Injection Site; Red from Shoulder to elbow; Swelling on the Injection Site; Pain on the Injection Site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE WARMTH (Warm to the touch Injection Site), VACCINATION SITE REACTION (Red from Shoulder to elbow), LIMB DISCOMFORT (A little Discomfort in Triceps Area on the Left Arm), INJECTION SITE PRURITUS (Very Itchy Injection Site) and INJECTION SITE SWELLING (Swelling on the Injection Site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE SWELLING (Swelling on the Injection Site) and INJECTION SITE PAIN (Pain on the Injection Site). On 19-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm to the touch Injection Site), VACCINATION SITE REACTION (Red from Shoulder to elbow) and INJECTION SITE PRURITUS (Very Itchy Injection Site). On 26-Feb-2021, the patient experienced LIMB DISCOMFORT (A little Discomfort in Triceps Area on the Left Arm). The patient was treated with CEFALEXIN MONOHYDRATE (KEFLEX [CEFALEXIN MONOHYDRATE]) at a dose of 500 mg four times per day. At the time of the report, INJECTION SITE WARMTH (Warm to the touch Injection Site), VACCINATION SITE REACTION (Red from Shoulder to elbow), LIMB DISCOMFORT (A little Discomfort in Triceps Area on the Left Arm), INJECTION SITE PRURITUS (Very Itchy Injection Site), INJECTION SITE SWELLING (Swelling on the Injection Site) and INJECTION SITE PAIN (Pain on the Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Other treatment medications include Benadryl cream and  Ice pack on the area for an unknown indication.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Soreness; Nause; Fever; Headaches; Muscle Hurts; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), NAUSEA (Nause), PYREXIA (Fever), HEADACHE (Headaches) and MYALGIA (Muscle Hurts) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 22-Feb-2021, the patient experienced PAIN (Soreness), NAUSEA (Nause), PYREXIA (Fever), HEADACHE (Headaches) and MYALGIA (Muscle Hurts). On 24-Feb-2021, PAIN (Soreness), NAUSEA (Nause), PYREXIA (Fever), HEADACHE (Headaches) and MYALGIA (Muscle Hurts) had resolved.            No relevant concomitant medications were reported. Treatment medicine include Extra Strength Tylenol
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced COVID-19 (tested positive for covid). At the time of the report, COVID-19 (tested positive for covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.